Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;157(6):1435-1441.
doi: 10.1016/j.chest.2019.12.035. Epub 2020 Jan 23.

Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry

Affiliations

Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry

Alice M Cottee et al. Chest. 2020 Jun.

Abstract

Background: Persistent bronchodilator response (BDR) following diagnosis of asthma is an underrecognized treatable trait, associated with worse lung function and asthma control. The forced oscillation technique (FOT) measures respiratory system impedance, and BDR cutoffs have been proposed for healthy adults; however, the relevance in asthma is unknown. We compared BDR cutoffs, using FOT and spirometry, in asthma and the relationship with asthma control.

Methods: Data from patients with asthma who withheld bronchodilator medication for at least 8 h before a tertiary airway clinic visit were reviewed. All subjects performed FOT and spirometry before and after salbutamol administration, and completed the Asthma Control Test. FOT parameters examined included respiratory system resistance (R5) and reactance (X5) at 5 Hz, and area under the reactance curve (AX). BDR was defined by standard recommendations for spirometry and based on the 95th percentile of BDR in healthy adults for FOT.

Results: Fifty-two subjects (18 men; mean age, 53 ± 18 years) were included. BDR was identified more frequently by FOT than spirometry (54% vs 27% of subjects). BDR assessed by X5 and AX, but not R5, was associated with spirometric BDR (χ2, P < .01) and correlated with asthma control (X5: rs = -0.36, P < .01; AX: rs = 0.34, P = .01). BDR measured by reactance parameters identified more subjects with poor asthma control than did spirometry (AX, 69% vs spirometry, 41%).

Conclusions: BDR assessed by FOT can identify poor asthma control. Reactance parameters were more sensitive in identifying poor asthma control than spirometry, supporting the use of FOT to complement spirometry in the clinical management of asthma.

Keywords: asthma control; bronchodilator response; forced oscillation technique; symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison between bronchodilator response (BDR) identified by spirometry and forced oscillation technique (FOT). Shown are the following: cutoff for identifying BDR by spirometry (blue line) and FOT (orange line); subjects with (blue circles) or without (red circles) BDR in FEV1 and/or FVC as assessed by spirometry; region of BDR concordance between spirometry and FOT (orange-shaded areas); Cohen’s κ; change in parameter after bronchodilator administration (postbronchodilator minus prebronchodilator) (Δ). Spirometric BDR is defined as ≥ 200 mL and ≥ 12% improvement in FEV1 and/or FVC.
Figure 2
Figure 2
Association between the presence of BDR and asthma control. Shown are the following: cutoff for poor asthma control (Asthma Control Test score < 20) (blue line); cutoff for BDR by spirometry or FOT (orange line); subjects with spirometric BDR (blue circles) or no spirometric BDR (red circles) in FEV1 and/or FVC; region of concordance between BDR and poor asthma control (orange-shaded areas); Spearman’s correlation (rs); change in parameter after bronchodilator administration (postbronchodilator minus prebronchodilator) (Δ). Spirometric BDR is defined as ≥ 200 mL and ≥ 12% improvement in FEV1 and/or FVC. ACT = Asthma Control Test; AX = area under the reactance curve, between 5 Hz and resonant frequency; R5 = resistance at 5 Hz; X5 = reactance at 5 Hz. See Figure 1 legend for expansion of other abbreviations.

Comment in

  • Criteria for Airway Oscillometry Reversibility in Asthma.
    Lipworth B, Chan R, Kuo CR. Lipworth B, et al. Chest. 2020 Sep;158(3):1282-1283. doi: 10.1016/j.chest.2020.03.048. Chest. 2020. PMID: 32892863 No abstract available.
  • Response.
    Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Cottee AM, et al. Chest. 2020 Sep;158(3):1283-1284. doi: 10.1016/j.chest.2020.03.047. Chest. 2020. PMID: 32892864 No abstract available.
  • Regression Artifacts: Bronchodilator Response and Regression to the Mean.
    Eliasson O. Eliasson O. Chest. 2020 Dec;158(6):2697-2698. doi: 10.1016/j.chest.2020.06.087. Chest. 2020. PMID: 33280751 No abstract available.
  • Response.
    Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Cottee AM, et al. Chest. 2020 Dec;158(6):2698-2699. doi: 10.1016/j.chest.2020.07.044. Chest. 2020. PMID: 33280752 No abstract available.

References

    1. Wells K.E., Cajigal S., Peterson E.L. Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects. J Allergy Clin Immunol. 2016;137(5):1364–1369. - PMC - PubMed
    1. Kim J.-K., Jung J.-Y., Kim H., Eom S.-Y., Hahn Y.-S. Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma. Respirology. 2017;22(3):466–472. - PubMed
    1. Szefler S.J., Martin R.J., King T.S. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109(3):410–418. - PubMed
    1. Heffler E., Crimi C., Campisi R. Bronchodilator response as a marker of poor asthma control. Respir Med. 2016;112:45–50. - PubMed
    1. Busse W.W., Holgate S.T., Wenzel S.W. Biomarker profiles in asthma with high vs low airway reversibility and poor disease control. Chest. 2015;148(6):1489–1496. - PMC - PubMed

Substances